Teela Lorynn, Luijten Michiel A J, Kuijlaars Isolde A R, van Gastel Tessa C M, van Hoorn Evelien S, Gouw Samantha C, Fijnvandraat Karin C J, Fischer Kathelijn, Cnossen Marjon H, Andeweg Sasja, van der Velden-van 't Hoff Carolien, Liem Corinne, Jansen-Zijlstra Margreet E, Peters Marjolein, Haverman Lotte
Amsterdam UMC location University of Amsterdam, Emma Children's Hospital, Child and Adolescent Psychiatry & Psychosocial Care, Amsterdam, The Netherlands.
Amsterdam Public Health, Mental health and Digital health, Amsterdam, The Netherlands.
Res Pract Thromb Haemost. 2023 Aug 2;7(6):102159. doi: 10.1016/j.rpth.2023.102159. eCollection 2023 Aug.
The use of patient-reported outcomes measures (PROMs) is important in hemophilia care, as it facilitates communication between patients and clinicians and promotes patient-centered care. Currently, a variety of PROMs with insufficient psychometric properties are used. Patient-reported outcomes measurement information system (PROMIS) measures, including Computer Adaptive Tests, were designed to measure generically and more efficiently and, therefore, are an alternative for the existing PROMs.
To assess the feasibility, measurement properties, and outcomes of 8 PROMIS pediatric measures for boys with hemophilia.
In this multicenter study, boys with hemophilia completed 8 PROMIS measures and 2 legacy instruments. Feasibility was determined by the number of completed items and floor or ceiling effects (percentage of participants that achieved the lowest or highest possible score). Reliability was assessed as the percentage of scores with a SE ≤ 4.5. Construct validity was evaluated by comparing the PROMIS measures with the legacy instruments. Mean PROMIS T-scores were calculated and compared with the Dutch general population.
In total, 77 boys with hemophilia participated. Reliability was good for almost all PROMIS measures and legacy instruments. The total number of completed items varied from 49 to 90 for the PROMIS pediatric measures, while the legacy instruments contained 117 to 130 items. Floor and ceiling effects were observed in both the PROMIS measures (0-39.5%) and legacy instruments (0-66.7%), but were higher for the legacy instruments.
The PROMIS pediatric measures are feasible to use for boys with hemophilia. With the use of the PROMIS measures in clinical care and research, a step toward worldwide standardization of PROM administration can be taken.
患者报告结局量表(PROMs)在血友病护理中具有重要作用,因为它有助于患者与临床医生之间的沟通,并促进以患者为中心的护理。目前,使用的各种PROMs的心理测量特性不足。患者报告结局测量信息系统(PROMIS)量表,包括计算机自适应测试,旨在进行通用且更高效的测量,因此是现有PROMs的一种替代方案。
评估8种PROMIS儿科量表在血友病男孩中的可行性、测量特性和结局。
在这项多中心研究中,血友病男孩完成了8种PROMIS量表和2种传统工具。可行性通过完成项目的数量以及地板效应或天花板效应(获得最低或最高可能分数的参与者百分比)来确定。可靠性评估为标准误≤4.5的分数百分比。通过将PROMIS量表与传统工具进行比较来评估结构效度。计算PROMIS平均T分数并与荷兰普通人群进行比较。
共有77名血友病男孩参与。几乎所有PROMIS量表和传统工具的可靠性都很好。PROMIS儿科量表完成项目的总数在49至90项之间,而传统工具包含117至130项。在PROMIS量表(0 - 39.5%)和传统工具(0 - 66.7%)中均观察到地板效应和天花板效应,但传统工具的效应更高。
PROMIS儿科量表可用于血友病男孩。在临床护理和研究中使用PROMIS量表,可以朝着PROM管理的全球标准化迈出一步。